CTA-Sticky-button.png clinicaltrialsyearbook+button

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player


Delivering localised clinical outsourcing and operations strategies

The global OCT series extends to Switzerland in 2018 to bring innovative and solutions-focused content to the DACH biopharmaceutical market.  Spinning off from the flagship OCT Europe event, this intimate audience of local players allows for focused, lucrative learning and networking on site.

Through in depth research conducted with local biopharma companies, this event will deliver insight, debate, discussion, presentation and opinion on high priority outsourcing, operations and technology based themes within the clinical trial space locally.


Event News

Who should attend OCT DACH?

The OCT series provides an opportunity for all clinical trial Sponsors to extend their network both with industry colleagues and providers of services and solutions which enhance the output of clinical trials.

OCT Global Series

The objective of the OCT series is to deliver relevant content and networking to localised biopharma and device markets across the world. The events take place in biopharma clusters to support the local biopharma community in their clinical trial delivery.

Partnership Opportunities

OCT DACH will provide local biopharma with numerous opportunities to meet potential future Partners for clinical trial activity. A varied exhibition of providers who can support specific biopharma requirements and expectations allow for lucrative networking during the many breaks and opportunities throughout the event.

Countdown to Outsourcing in Clinical Trials DACH 2018